{"id":"https://openalex.org/W4385168796","doi":"https://doi.org/10.1158/1078-0432.23717520.v1","title":"Supplementary Figure S6 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non\u2013Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA","display_name":"Supplementary Figure S6 from Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non\u2013Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA","publication_year":2023,"publication_date":"2023-07-20","ids":{"openalex":"https://openalex.org/W4385168796","doi":"https://doi.org/10.1158/1078-0432.23717520.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.23717520.v1","doi":"https://doi.org/10.1158/1078-0432.23717520.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.23717520.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S6_from_Early_Clearance_of_Plasma_i_Epidermal_Growth_Factor_Receptor_i_Mutations_as_a_Predictor_of_Outcome_on_Osimertinib_in_Advanced_Non_Small_Cell_Lung_Cancer_Exploratory_Analysis_from_AURA3_and_FLAURA/23717520/1/files/41629068.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S6_from_Early_Clearance_of_Plasma_i_Epidermal_Growth_Factor_Receptor_i_Mutations_as_a_Predictor_of_Outcome_on_Osimertinib_in_Advanced_Non_Small_Cell_Lung_Cancer_Exploratory_Analysis_from_AURA3_and_FLAURA/23717520/1/files/41629068.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007121755","display_name":"Jhanelle E. Gray","orcid":"https://orcid.org/0000-0003-1304-7062","observed_orcids":["https://orcid.org/0000-0003-1304-7062"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jhanelle E. Gray","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1304-7062","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034739279","display_name":"Myung\u2010Ju Ahn","orcid":"https://orcid.org/0000-0002-5740-9654","observed_orcids":["https://orcid.org/0000-0002-5740-9654","https://orcid.org/0000-0002-5376-5109"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Myung-Ju Ahn","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5740-9654","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045665778","display_name":"Geoffrey R. Oxnard","orcid":"https://orcid.org/0000-0003-1054-8240","observed_orcids":["https://orcid.org/0000-0003-1054-8240"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoffrey R. Oxnard","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1054-8240","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075347427","display_name":"Frances A. Shepherd","orcid":"https://orcid.org/0000-0002-3610-3533","observed_orcids":["https://orcid.org/0000-0002-3610-3533"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frances A. Shepherd","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3610-3533","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047714811","display_name":"Fumio Imamura","orcid":"https://orcid.org/0009-0009-5961-2101","observed_orcids":["https://orcid.org/0009-0009-5961-2101"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fumio Imamura","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-5961-2101","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057704753","display_name":"Ying Cheng","orcid":"https://orcid.org/0000-0001-9908-597X","observed_orcids":["https://orcid.org/0000-0001-9908-597X","https://orcid.org/0009-0006-2718-2969"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ying Cheng","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9908-597X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072724155","display_name":"Isamu Okamoto","orcid":"https://orcid.org/0000-0002-7587-6096","observed_orcids":["https://orcid.org/0000-0002-7587-6096"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isamu Okamoto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7587-6096","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064697305","display_name":"Byoung Chul Cho","orcid":"https://orcid.org/0000-0002-5562-270X","observed_orcids":["https://orcid.org/0000-0002-5562-270X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Byoung Chul Cho","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5562-270X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048313601","display_name":"Meng\u2010Chih Lin","orcid":"https://orcid.org/0000-0001-8333-1494","observed_orcids":["https://orcid.org/0000-0001-8333-1494"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meng-Chih Lin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8333-1494","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100632072","display_name":"Yi-Long Lung Cancer Wu","orcid":"https://orcid.org/0000-0002-3611-0258","observed_orcids":["https://orcid.org/0000-0002-3611-0258"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi-Long Wu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3611-0258","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059355812","display_name":"Margarita Majem","orcid":"https://orcid.org/0000-0002-9919-7485","observed_orcids":["https://orcid.org/0000-0002-9919-7485"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margarita Majem","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9919-7485","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070375776","display_name":"Oliver Pascal Gautschi","orcid":"https://orcid.org/0009-0000-3137-3254","observed_orcids":["https://orcid.org/0009-0000-3137-3254"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Gautschi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-3137-3254","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077287358","display_name":"Michael Joseph Boyer","orcid":"https://orcid.org/0000-0002-0452-2987","observed_orcids":["https://orcid.org/0000-0002-0452-2987"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Boyer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0452-2987","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023192928","display_name":"Krishna C. Bulusu","orcid":"https://orcid.org/0000-0002-5092-6640","observed_orcids":["https://orcid.org/0000-0002-5092-6640"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Krishna C. Bulusu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5092-6640","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059123004","display_name":"Aleksandra A. Markovets","orcid":"https://orcid.org/0000-0003-0957-0424","observed_orcids":["https://orcid.org/0000-0003-0957-0424"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleksandra Markovets","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0957-0424","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045263771","display_name":"J. Carl Barrett","orcid":"https://orcid.org/0000-0003-4042-9859","observed_orcids":["https://orcid.org/0000-0003-4042-9859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Carl Barrett","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4042-9859","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055204234","display_name":"Rachel A. Hodge","orcid":"https://orcid.org/0009-0009-3869-2835","observed_orcids":["https://orcid.org/0009-0009-3869-2835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Hodge","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-3869-2835","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001577825","display_name":"Astrid McKeown","orcid":"https://orcid.org/0009-0007-7240-4708","observed_orcids":["https://orcid.org/0009-0007-7240-4708"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Astrid McKeown","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-7240-4708","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053871500","display_name":"Ryan James Hartmaier","orcid":"https://orcid.org/0000-0001-7416-6036","observed_orcids":["https://orcid.org/0000-0001-7416-6036"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryan J. Hartmaier","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7416-6036","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063661642","display_name":"Juliann Chmielecki","orcid":"https://orcid.org/0009-0001-1113-0164","observed_orcids":["https://orcid.org/0009-0001-1113-0164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juliann Chmielecki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-1113-0164","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008790176","display_name":"Vassiliki A. Papadimitrakopoulou","orcid":"https://orcid.org/0000-0003-3172-1399","observed_orcids":["https://orcid.org/0000-0003-3172-1399"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vassiliki A. Papadimitrakopoulou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3172-1399","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088178599","display_name":"Suresh S. Ramalingam","orcid":"https://orcid.org/0000-0002-0757-3106","observed_orcids":["https://orcid.org/0000-0002-0757-3106"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suresh S. Ramalingam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0757-3106","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osimertinib","display_name":"osimertinib","score":0.8479999899864197},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8140000104904175},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9070000052452087},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/flaura-trial","display_name":"FLAURA trial","score":0.8190000057220459},{"id":"https://openalex.org/keywords/aura3-trial","display_name":"AURA3 trial","score":0.8920000195503235},{"id":"https://openalex.org/keywords/ex19del","display_name":"ex19del","score":0.8489999771118164},{"id":"https://openalex.org/keywords/l858r","display_name":"L858R","score":0.9409999847412109},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6819999814033508}],"concepts":[{"id":"https://openalex.org/C2777626846","wikidata":"https://www.wikidata.org/wiki/Q21506464","display_name":"Osimertinib","level":5,"score":0.9286586046218872},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6368181705474854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6114802956581116},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5933391451835632},{"id":"https://openalex.org/C3017575891","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma levels","level":2,"score":0.5293180346488953},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5070157051086426},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48957595229148865},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.48218217492103577},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.4206109941005707},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.32339033484458923},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0787685215473175},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.23717520.v1","doi":"https://doi.org/10.1158/1078-0432.23717520.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.23717520.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S6_from_Early_Clearance_of_Plasma_i_Epidermal_Growth_Factor_Receptor_i_Mutations_as_a_Predictor_of_Outcome_on_Osimertinib_in_Advanced_Non_Small_Cell_Lung_Cancer_Exploratory_Analysis_from_AURA3_and_FLAURA/23717520/1/files/41629068.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/23717520","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_S6_from_Early_Clearance_of_Plasma_i_Epidermal_Growth_Factor_Receptor_i_Mutations_as_a_Predictor_of_Outcome_on_Osimertinib_in_Advanced_Non_Small_Cell_Lung_Cancer_Exploratory_Analysis_from_AURA3_and_FLAURA/23717520","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.23717520.v1","doi":"https://doi.org/10.1158/1078-0432.23717520.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.23717520.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S6_from_Early_Clearance_of_Plasma_i_Epidermal_Growth_Factor_Receptor_i_Mutations_as_a_Predictor_of_Outcome_on_Osimertinib_in_Advanced_Non_Small_Cell_Lung_Cancer_Exploratory_Analysis_from_AURA3_and_FLAURA/23717520/1/files/41629068.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6800000071525574,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385168796.pdf","grobid_xml":"https://content.openalex.org/works/W4385168796.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4220695811","https://openalex.org/W4310754288","https://openalex.org/W2797413838","https://openalex.org/W4224041292","https://openalex.org/W4386377637","https://openalex.org/W2801867313","https://openalex.org/W4295169001","https://openalex.org/W4386374066","https://openalex.org/W4226085616","https://openalex.org/W3021901023"],"abstract_inverted_index":{"Kaplan\u2013Meier":[0],"estimates":[1],"showing":[2],"investigator-assessed":[3],"PFS":[4],"in":[5,22],"FLAURA":[6],"trial":[7],"patients":[8,23,32],"by":[9,43,56,68,81,94],"clearance":[10],"or":[11,20,108],"non-clearance":[12],"of":[13],"plasma":[14,28,36,46,59,71,84],"EGFRm":[15,37,47,60,72,85],"status":[16,48,61,73,86],"at":[17],"Weeks":[18],"3":[19,45,58],"6":[21,70,83],"who":[24],"had":[25],"baseline":[26,34],"detectable":[27],"EGFRm.":[29],"For":[30],"comparison,":[31],"with":[33],"non-detectable":[35],"are":[38,92],"included.":[39],"A,":[40],"Osimertinib":[41,66],"arm":[42,55,67,80],"Week":[44,57,69,82],"(n":[49,62,74,87],"=":[50,63,75,88],"238).":[51],"B,":[52],"Comparator":[53,78],"EGFR-TKI":[54,79],"243).":[64],"C,":[65],"240).":[76],"D,":[77],"235).":[89],"Censored":[90],"data":[91],"indicated":[93],"tick":[95],"marks.":[96],"Abbreviations:":[97],"CI,":[98],"confidence":[99],"interval;":[100],"EGFRm,":[101],"epidermal":[102],"growth":[103],"factor":[104],"receptor":[105],"mutation":[106],"(ex19del":[107],"L858R);":[109],"NC,":[110],"not":[111],"calculable;":[112],"mPFS,":[113],"median":[114],"PFS;":[115],"TKI,":[116],"tyrosine":[117],"kinase":[118],"inhibitor.":[119]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}